Published in Br Med J on August 10, 1974
Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J (1980) 1.20
Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones. Gut (1977) 1.04
Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Br J Clin Pharmacol (1978) 0.99
The common hyperlipidaemias. Postgrad Med J (1976) 0.76
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 6.51
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet (1972) 4.54
The fluorometric assay of triglyceride by a semiautomated method. Anal Biochem (1968) 3.37
Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest (1973) 2.65
Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet (1972) 2.59
The Oslo diet-heart study. Eleven-year report. Circulation (1970) 2.10
Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets. Circ Res (1972) 1.96
Treatment of hyperlipidemias. Am J Med (1968) 1.72
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J Clin Invest (1972) 1.46
Hyper- -lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides. Acta Med Scand (1972) 1.40
Controlled trial of soya-bean oil in myocardial infarction. Lancet (1968) 1.35
Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region. Br Med J (1971) 0.95
Dextrothyroxine with propranolol in treatment of hypercholesterolaemia. Lancet (1971) 0.94
A long-term coronary prevention evaluation program. Ann N Y Acad Sci (1968) 0.85
Lipoprotein lipid alterations with cholestyramine administration. J Lab Clin Med (1970) 0.84
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest (1993) 2.89
Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87
Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet (1984) 2.87
Molecular cloning and expression of Campylobacter pylori species-specific antigens in Escherichia coli K-12. Infect Immun (1989) 2.81
Acupressure and the prevention of nausea and vomiting after laparoscopy. Br J Anaesth (1999) 2.77
Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75
BINOCULAR VISION IN MINERS. Br J Ophthalmol (1948) 2.73
Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut (1991) 2.64
The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis (1986) 2.61
Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest (1984) 2.53
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut (2008) 2.51
Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 2.49
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol (2001) 2.42
Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2000) 2.41
Cimetidine and HDL cholesterol. Lancet (1983) 2.40
Nucleotide sequence of two genes from Helicobacter pylori encoding for urease subunits. Nucleic Acids Res (1990) 2.38
Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet (1968) 2.36
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23
Detection of pathogenic Yersinia enterocolitica by the polymerase chain reaction. Lancet (1990) 2.23
Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment. Gut (1981) 2.21
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.07
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Jejunal bacteriology and bile-salt metabolism in patients with intestinal malabsorption. Lancet (1966) 2.03
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest (1986) 2.01
Pollination biology in a lowland dipterocarp forest inSarawak, Malaysia. I. Characteristics of the plant-pollinator communityin a lowland dipterocarp forest. Am J Bot (1998) 2.00
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother (1994) 1.98
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 1.93
Immunoblot analysis of the serological response in systemic candidosis. Lancet (1984) 1.90
Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol (1983) 1.89
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest (1966) 1.88
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest (1975) 1.82
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
Dehydration of a phosphonate substrate analogue by glycerol 3-phosphate dehydrogenase. Biochem J (1974) 1.80
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) (1981) 1.80
10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality. Lancet (1980) 1.78
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology. Circulation (1996) 1.76
Bacteria, bile, and the small bowel. Gut (1969) 1.74
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol (1992) 1.74
Epidemic perinatal listeriosis. Pediatr Infect Dis (1984) 1.74
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
Escherichia coli antibodies in patients with inflammatory bowel disease. Gut (1978) 1.73
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
One-minute endoscopy room test for Campylobacter pylori. Lancet (1988) 1.64
Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci U S A (1983) 1.64
Method for the typing of Clostridium difficile based on polyacrylamide gel electrophoresis of [35S]methionine-labeled proteins. J Clin Microbiol (1986) 1.64
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion. BMJ (2003) 1.62
Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet (1981) 1.61
The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem (1987) 1.61
Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg (1998) 1.59
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J Gen Microbiol (1990) 1.57
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr (1997) 1.57
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest (1980) 1.55
Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr (1998) 1.53
Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry (1988) 1.52
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation (1998) 1.52
Switchable Polymer Based Thin Film Coils as a Power Module for Wireless Neural Interfaces. Sens Actuators A Phys (2007) 1.52
Serum bile acids in liver disease. Gut (1971) 1.50
RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49
Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol (2008) 1.48
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res (1975) 1.47
A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile. Gene (1996) 1.47
Ascorbic acid clearance in diabetic nephropathy. J Diabetes Complications (1998) 1.47
Pre-admission clinic in an orthopaedic department: evaluation over a 6-month period. J R Coll Surg Edinb (1998) 1.46
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res (1983) 1.46
Delayed health hazards of pesticide exposure. Annu Rev Public Health (1986) 1.45
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther (2007) 1.45
Campylobacter species in male homosexuals. Br J Vener Dis (1979) 1.45
Postnucleation droplet growth in supersaturated gas with arbitrary vapor concentration. J Chem Phys (2004) 1.44
Prosthodontic rehabilitation of midfacial defects. J Prosthet Dent (1985) 1.44
The clinical importance of gram-positive anaerobic cocci isolated at St Bartholomew's Hospital, London, in 1987. J Med Microbiol (1994) 1.44
Characterization of a plasmid from Helicobacter pylori encoding a replication protein common to plasmids in gram-positive bacteria. Mol Microbiol (1991) 1.43
Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J R Soc Interface (2009) 1.42
Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect (2001) 1.42
A selective enrichment broth for the isolation of Clostridium difficile. J Clin Pathol (1984) 1.41
Relationship of toxin production to species in the genus Aeromonas. J Med Microbiol (1986) 1.41
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest (1992) 1.40
Colo-anal intussusception in an adult: case report and review of the literature. Int J Clin Pract (2009) 1.40